Your browser doesn't support javascript.
loading
Engineering and optimization of the miR-106b cluster for ectopic expression of multiplexed anti-HIV RNAs.
Aagaard, L A; Zhang, J; von Eije, K J; Li, H; Saetrom, P; Amarzguioui, M; Rossi, J J.
  • Aagaard LA; Division of Molecular Biology, Beckman Research Institute of City of Hope, Duarte, CA, USA.
Gene Ther ; 15(23): 1536-49, 2008 Dec.
Article en En | MEDLINE | ID: mdl-18800151
ABSTRACT
Many microRNAs (miRNAs) are encoded within the introns of RNA Pol II transcripts, often as polycistronic precursors. Here, we demonstrate the optimization of an intron encoding three endogenous miRNAs for the ectopic expression of heterologous anti-HIV-1 small interfering RNAs (siRNAs) processed from a single RNA polymerase II primary miRNA. Our expression system, designated as MCM7, is engineered from the intron-embedded, tri-cistronic miR-106b cluster that endogenously expresses miR-106b, miR-93 and miR-25. Manipulation of the miR-106b cluster demonstrated a strict requirement for maintenance of the native flanking primary miRNA (pri-miRNA) sequences and key structural features of the native miRNAs for efficient siRNA processing. As a model for testing the efficacy of this approach, we have replaced the three endogenous miRNAs with siRNAs targeting the tat and rev transcripts of human immunodeficiency virus type 1 (HIV-1). This study has enabled us to establish guidelines for optimal processing of the engineered miRNA mimics into functional siRNAs. In addition, we demonstrate that the incorporation of a small nucleolar RNA TAR chimeric decoy (snoRNA) inserted within the MCM7 intron resulted in a substantial enhancement of HIV suppression in long-term acute infectious HIV-1 challenges.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapia Genética / Infecciones por VIH / VIH-1 / MicroARNs / ARN Interferente Pequeño Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2008 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapia Genética / Infecciones por VIH / VIH-1 / MicroARNs / ARN Interferente Pequeño Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2008 Tipo del documento: Article